{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:29:51Z","timestamp":1765456191784,"version":"3.46.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:00:00Z","timestamp":1760832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013103","name":"Shanghai General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115702","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:33:20Z","timestamp":1761122000000},"page":"115702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immune landscape and molecular regulators in renal interstitial fibrosis"],"prefix":"10.1016","volume":"167","author":[{"given":"Meng","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayijiaken","family":"Kasimumali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2025.115702_bb0005","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.18632\/aging.102811","article-title":"Adiponectin in renal fibrosis","volume":"12","author":"Jing","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"10","key":"10.1016\/j.intimp.2025.115702_bb0010","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/s41591-022-01990-1","article-title":"The global burden of disease study at 30 years","volume":"28","author":"Murray","year":"2022","journal-title":"Nat. Med."},{"issue":"21","key":"10.1016\/j.intimp.2025.115702_bb0015","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2019.17379","article-title":"Development of risk prediction equations for incident chronic kidney disease","volume":"322","author":"Nelson","year":"2019","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.intimp.2025.115702_bb0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12882-020-01761-5","article-title":"Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey","volume":"21","author":"Duan","year":"2020","journal-title":"BMC Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115702_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21873\/invivo.11019","article-title":"Pathophysiological mechanisms of renal fibrosis: a review of animal models and therapeutic strategies","volume":"31","author":"Nogueira","year":"2017","journal-title":"In Vivo"},{"key":"10.1016\/j.intimp.2025.115702_bb0030","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1046\/j.1523-1755.2000.07509.x","article-title":"The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease","volume":"75","author":"Klahr","year":"2000","journal-title":"Kidney Int. Suppl."},{"issue":"1","key":"10.1016\/j.intimp.2025.115702_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7888\/juoeh.38.25","article-title":"Mechanism of and therapy for kidney fibrosis","volume":"38","author":"Kuma","year":"2016","journal-title":"J. UOEH"},{"issue":"2","key":"10.1016\/j.intimp.2025.115702_bb0040","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1681\/ASN.2008121226","article-title":"New insights into epithelial-mesenchymal transition in kidney fibrosis","volume":"21","author":"Liu","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115702_bb0045","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrneph.2011.149","article-title":"Cellular and molecular mechanisms of renal fibrosis","volume":"7","author":"Liu","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115702_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrneph.2014.246","article-title":"Diverse origins of the myofibroblast\u2014implications for kidney fibrosis","volume":"11","author":"Falke","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115702_bb0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.115702_bb0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2017.12.016","article-title":"Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets","volume":"820","author":"Lv","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"7970","key":"10.1016\/j.intimp.2025.115702_bb0065","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-023-05769-3","article-title":"An atlas of healthy and injured cell states and niches in the human kidney","volume":"619","author":"Lake","year":"2023","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.intimp.2025.115702_bb0070","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.4049\/jimmunol.0901473","article-title":"Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations","volume":"183","author":"Lin","year":"2009","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115702_bb0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12079-017-0382-x","article-title":"B lymphocytes in renal interstitial fibrosis","volume":"11","author":"Zhu","year":"2017","journal-title":"J Cell Commun Signal"},{"issue":"2","key":"10.1016\/j.intimp.2025.115702_bb0080","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1681\/ASN.2010050548","article-title":"Kidney dendritic cells become pathogenic during crescentic glomerulonephritis with proteinuria","volume":"22","author":"Hochheiser","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115702_bb0085","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1369\/0022155419849388","article-title":"Extracellular matrix in kidney fibrosis: more than just a scaffold","volume":"67","author":"B\u00fclow","year":"2019","journal-title":"J. Histochem. Cytochem."},{"issue":"3","key":"10.1016\/j.intimp.2025.115702_bb0090","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","article-title":"Macrophages: versatile players in renal inflammation and fibrosis","volume":"15","author":"Tang","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2025.115702_bb0095","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2025.115702_bb0100","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.intimp.2025.115702_bb0105","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cell.2023.02.027","article-title":"Human T cell generation is restored in CD3\u03b4 severe combined immunodeficiency through adenine base editing","volume":"186","author":"McAuley","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115702_bb0110","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3389\/fimmu.2019.00856","article-title":"The emerging epigenetic role of CD8+T cells in autoimmune diseases: a systematic review","volume":"10","author":"Deng","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115702_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15112871","article-title":"Cellular and molecular mechanisms of liver fibrosis in patients with NAFLD","volume":"15","author":"Sanchez","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"19","key":"10.1016\/j.intimp.2025.115702_bb0120","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1056\/NEJMoa031178","article-title":"Effect of CD3delta deficiency on maturation of alpha\/beta and gamma\/delta T-cell lineages in severe combined immunodeficiency","volume":"349","author":"Dadi","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"29","key":"10.1016\/j.intimp.2025.115702_bb0125","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034295","article-title":"CD3D and CD247 are the molecular targets of septic shock","volume":"102","author":"Yang","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"21","key":"10.1016\/j.intimp.2025.115702_bb0130","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401879R","article-title":"CD3D silencing alleviates diabetic nephropathy via inhibition of JAK\/STAT pathway","volume":"38","author":"Lei","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2025.115702_bb0135","article-title":"CCL5 suppresses klotho expression via p-STAT3\/DNA Methyltransferase1-mediated promoter Hypermethylation","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2025.115702_bb0140","article-title":"Myeloid-derived suppressor cells alleviate renal fibrosis progression via regulation of CCL5-CCR5 Axis","volume":"12","author":"Qiu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115702_bb0145","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.2147\/DDDT.S386805","article-title":"Liquiritin protects against cardiac fibrosis after myocardial infarction by inhibiting CCL5 expression and the NF-\u03baB signaling pathway","volume":"16","author":"Han","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2025.115702_bb0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ncpneph0418","article-title":"Mechanisms of disease: regulation of RANTES (CCL5) in renal disease","volume":"3","author":"Krensky","year":"2007","journal-title":"Nat. Clin. Pract. Nephrol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115702_bb0155","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.1523-1755.2000.00311.x","article-title":"Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy","volume":"58","author":"Wada","year":"2000","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.intimp.2025.115702_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158156","article-title":"Antifibrotic effects of the dual CCR2\/CCR5 antagonist Cenicriviroc in animal models of liver and kidney fibrosis","volume":"11","author":"Lefebvre","year":"2016","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.intimp.2025.115702_bb0165","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.29170","article-title":"Hepatitis C virus-induced CCL5 secretion from macrophages activates hepatic stellate cells","volume":"66","author":"Sasaki","year":"2017","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.intimp.2025.115702_bb0170","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1172\/JCI41732","article-title":"Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice","volume":"120","author":"Berres","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.115702_bb0175","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.phrs.2017.02.026","article-title":"The role of chemokines in hypertension and consequent target organ damage","volume":"119","author":"Rudemiller","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2025.115702_bb0180","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3389\/fimmu.2020.01090","article-title":"CD2 Immunobiology","volume":"11","author":"Binder","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115702_bb0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00041552-200101000-00004","article-title":"CD2-associated protein and the kidney","volume":"10","author":"Shaw","year":"2001","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"12","key":"10.1016\/j.intimp.2025.115702_bb0190","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41590-019-0479-x","article-title":"Flip the coin: IL-7 and IL-7R in health and disease","volume":"20","author":"Barata","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.115702_bb0195","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.3389\/fimmu.2017.01970","article-title":"Overview of the mechanisms that may contribute to the non-redundant activities of interferon-inducible CXC chemokine receptor 3 ligands","volume":"8","author":"Metzemaekers","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115702_bb0200","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.2147\/IJN.S115044","article-title":"Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis","volume":"11","author":"Choi","year":"2016","journal-title":"Int. J. Nanomedicine"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925016935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925016935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:26:39Z","timestamp":1765455999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925016935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"alternative-id":["S1567576925016935"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115702","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune landscape and molecular regulators in renal interstitial fibrosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115702"}}